Demonstrate the Safety and Preformance of the SRS Device for the Treatment of Pelvic Organ Prolapse

NCT02209337 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2019-08-16

No results posted yet for this study

Summary

A prospective, single arm, pre-market, multi-center clinical study to evaluate the safety and performance of the SRS (Lyra Medical) vaginal mesh in POP patients

Conditions

  • Anterior Vaginal Wall Prolapse
  • Vaginal Apex/Uterine Prolapse

Interventions

DEVICE

SRS

Sponsors & Collaborators

  • Lyra Medical Ltd.

    lead INDUSTRY

Principal Investigators

  • Gil Levi, Dr. · Mayanei HaYeshua Medical Center

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-09-30
Primary Completion
2016-03-31
Completion
2018-03-31

Countries

  • Hungary
  • Israel

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02209337 on ClinicalTrials.gov